Variceal hemorrhage in a patient with ulcerative colitis treated with 6-thioguanine

Inflammatory Bowel Diseases

Volumn 14, Issue 4, 2008, Pages 582-583

  Fritz, Eva ^a   Wrba, Friedrich ^b   Knoflach, Peter ^a  

^a Klinikum Wels   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; INFLIXIMAB; MESALAZINE; METHOTREXATE; PREDNISONE; TIOGUANINE;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ESOPHAGUS VARICES; FEMALE; GASTROSCOPY; HEPATITIS; HUMAN; LETTER; LEUKOPENIA; LIVER BIOPSY; LIVER TOXICITY; NODULAR HYPERPLASIA; NODULAR REGENERATIVE HYPERPLASIA; PANCREATITIS; PRIORITY JOURNAL; REGENERATIVE NODULAR HYPERPLASIA; ULCERATIVE COLITIS;

ANTIMETABOLITES; COLITIS, ULCERATIVE; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; HYPERPLASIA; LIVER; MIDDLE AGED; THIOGUANINE;

EID: 42449143849     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20323     Document Type: Letter

References (8)

1. Key NS, Kelly PM, Emerson PM, et al. Oesophageal varices associated with busulphanthioguanine combination therapy for chronic myeloid leukaemia. Lancet. 1987;2:1050-1052.
2. Vora A, Mitchell CD, Lennard L, et al. Toxixity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial. Lancet. 2006;368:1339-1348.
3. Dubinsky MC, Vasiliauskas EA, Singh H, et al. 6-Thioguanine can cause serious liver injury in inflammatory bowel disease patients. Gastroenterology. 2003;125:298-303.
4. Seiderer J, Zech CJ, Reinisch W, et al. A multicenter assessment of liver toxicity by MRI and biopsy in IBD patients on 6-thioguanine. J Hepatol 2005;43:303-309.
5. Gilisesen LP, Derijks LJ, Driessen A, et al. Toxicity of 6-thioguanine: no hepatotoxicity in a series of IBD patients treated with long-term, low dose 6-thioguanine. Some evidence for dose or metabolite level dependent effects? Dig Liver Dis. 2007;39:156-159.
6. De Boer NKH, Reinisch W, Teml A, et al. 6-Thioguanine treatment in inflammatory bowel disease: a critical appraisal by a European 6-TG working party. Digestion. 2006;73:25-31.
7. Herrlinger KR, Deibert P, Schwab M, et al. Remission maintenance by thioguanine in chronic active Crohn's disease. Aliment Pharmacol Ther. 2003;17:1459-1464.
8. Teml A, Schwab M, Harrer M, et al. A prospective open-label trial of 6-thioguanine in patients with ulcerative or indeterminate colitis. Scand J Gastroenterol. 2005;40:1205-1213.